Life scientist. AI, q-bio, systems biology.
Head, Open Science, @embo.org
Project Lead, @reviewcommons.org
@embopress.org
Loves 🎶 and plays the 🎻
Views my own
Thomas Lemberger
Loading...
It was a very cool experiment! The author-centric perspective makes a lot of sense.
An important next step is to benchmark multiple AI review platforms. Maybe this can also pave the way for benchmarking human peer review across journals and defining "quality features" of the peer review process.
Read this @emboreports.org paper here=> link.springer.com/article/10.1...
Cool 😎 Scholar Labs: an AI-powered Google Scholar search.
scholar.googleblog.com/2025/11/scho...
Our joint study with EMBO is just out! We are proud to be at the forefront of this sea change. AI will reinforce the central role of scientists in this new era. Strong science should be seen!
@embo.org @reviewcommons.org @tlemberger.bsky.social
link.springer.com/article/10.1...
The preprint #PeerReview platform Review Commons was launched at the 2019 ASCB | EMBO Meeting to make scientific #publishing more open and effective. Thomas Lemberger, lead of the initiative, tells us more about the platform: https://www.embo.org/features/review-commons-rethinking-peer-review/ 🧪
Honored to be included in this reflection on 20 excellent years of MolSystBiol! From our first phosphotyrosine interactome in 2005 to proteome-wide networks - scale has grown exponentially. MS proteomics + AI is transforming systems-level understanding. Exciting times!
embopress.org/doi/pdf/10.1...
Last week on 11–12 Sep, together with our publishing partner @springernature.com, EMBO hosted a workshop "AI to advance open science publishing” in Heidelberg, DE. 🧪 Participants engaged in demonstrations and experiments using tools developed by Springer Nature and EMBO for innovation in publishing.
It’s finally out! Together with @embopress.org and
@reviewcommons.org, we conducted a structured side-by-side comparison of human peer review and our AI scientific review (see thread 👇👇👇🔥).
Very cool! I agree AI scientific review can be useful if it is transparent. It is all progressing very fast and will change everything. @qedScience @bioRxiv is a great first step. We are doing some human-based eval, so more soon from @EMBOPress @ReviewCommons with @qedScience. Watch this space ;-)
IT'S HAPPENING! 💥 I'm psyched to launch the collaboration between @qedscience.bsky.social & @openrxiv.bsky.social @biorxivpreprint.bsky.social! Preprint + q.e.d = your science is out there, and anyone can appreciate it. Let's care about making discoveries, and not on “getting published” (1/3) 👇
